This contract expires in 325 days (Sep 13, 2027).
PHARMARON, INC - NCATS: SERVICE: PHARMACOKINETIC (PK) STUDIES FOR RXFP1-AGONISTS: SEVERABLE
Key Details
Description
NCATS: SERVICE: PHARMACOKINETIC (PK) STUDIES FOR RXFP1-AGONISTS: SEVERABLE
Context & Analysis
On Sep 11, 2026, Department of Health and Human Services obligated $19,296 to PHARMARON, INC for ncats: service: pharmacokinetic (pk) studies for rxfp1-agonists: severable. The award is classified under NAICS 541380 — TESTING LABORATORIES AND SERVICES. Competition extent: competed under sap with 3 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in ROCKVILLE, MD. The contract is scheduled through Sep 13, 2027 — approximately 11 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541380 — related awards are listed below.
Contractor Information
Similar Awards
TRAVELER-BASED GENOMIC SURVEILLANCE PROGRAM
GINKGO BIOWORKS, INC.
$78.0M
WASTEWATER SURVEILLANCE TESTING
VERILY HEALTH INC.
$42.3M
INNOVATION FUNNEL FOR COVID-19 - VALIDATION CENTER
EMORY UNIVERSITY
$41.2M
STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
$38.8M
CENTRALIZED OMICS RESOURCE (CORE) YEAR 5
THE BROAD INSTITUTE, INC
$36.4M
Stay Updated
Get notified about new opportunities matching your interests.